Top Markets
Coin of the day
ProtoKinetix, Incorporated ProtoKinetix, Incorporated

ProtoKinetix, Incorporated

PKTX
Rang in Aktien #40253
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and... ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.
Aktienkurs
$0.0005
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$195.79K
Veränderung (1 Tag)
25.00%
Veränderung (1 Jahr)
-92.09%
Land
US
Handel ProtoKinetix, Incorporated (PKTX)

Kategorie

EPS für ProtoKinetix, Incorporated (PKTX)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von ProtoKinetix, Incorporated beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von ProtoKinetix, Incorporated von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE